Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

NCT03018691 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: OPA-15406
DRUG: Placebos

Sponsor

Otsuka Pharmaceutical Co., Ltd.